Relationship between myocardial viability and improvement in left ventricular function and heart failure symptoms after coronary artery bypass surgery. by Peovska, Irena et al.
Prilozi, Odd. biol. med. nauki, MANU, XXVIII, 1, s.97–112 (2007) 
Contributions, Sec. Biol. Med. Sci., MASA, XXVIII, 1, p. 97–112 (2007) 
ISSN 0351–3254 
UDK: 616.127-073.916 
 
 
 
 
 
 
 
 
 
RELATIONSHIP BETWEEN MYOCARDIAL VIABILITY 
AND IMPROVEMENT IN LEFT VENTRICULAR FUNCTION 
AND HEART FAILURE SYMPTOMS AFTER 
CORONARY ARTERY BYPASS SURGERY 
 
Peovska I., Maksimovic J., Vavlukis M., Davceva J., Pop Gorceva D., 
Majstorov V., Kostova N., Bosevski M. 
 
Heart Diseases Institute, Pathophysiology and Nuclear Medicine Institute,  
Clinical Centre, Skopje, R. Macedonia 
 
 
A b s t r a c t: Background: The evaluation of myocardial viability is an impor-
tant preoperative parameter, predictive of improvement in regional and global left ventri-
cular (LV) function after coronary artery bypass surgery (CABG). However, whether the 
presence of viability is also associated with relief of heart failure symptoms after revasculari-
zation is not always certain. The aims of the study were to define the relationship between 
extent of viable myocardium and improvement in LV function after CABG and to determine 
whether preoperative viability testing can predict improvement in heart failure symptoms.  
Methods: Eighty-five consecutive patients with ischemic cardiomyopathy (mean 
LVEF 35%) undergoing surgical revascularization were studied with a Tc-99m sesta-
mibi one-day rest/nitrate enhanced myocardial perfusion SPECT imaging (MPI) to assess 
viability. Regional and global function were measured before and 16 ± 6 months after 
revascularization. We have used the Bull’s eye quantitative analysis of MPI scans and 
17 segment model of LV function and perfusion evaluation. Heart failure symptoms 
were graded according to the New York Heart Association (NYHA) criteria, before and 
16 ± 6 months after revascularization.  
Results: The number of viable segments per patient was directly related to the 
improvement in LVEF after revascularization (r 0.79, P < 0.01). Patients with > 4 viable 
segments representing 24% of the left ventricle yielded the sensitivity of 83% and specificity 
of 79% respectively for predicting improvement in LVEF. Furthermore, the presence of 
four or more viable segments predicted improvement in heart failure symptoms after re-
vascularization, with positive and negative predictive values of 79% and 74%, respectively.  
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Conclusion: The presence of substantial viability (four or more viable segments, 
24% of the left ventricle) on myocardial perfusion gated SPECT imaging in patients 
with ischemic heart failure before CABG surgery has significant correlation with the 
improvement in LVEF and heart failure symptoms postoperatively. 
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Introduction 
 
Treatment of patients with ischemic heart failure and severely depres-
sed left ventricular (LV) function remains challenging. Revascularization may 
substantially improve heart failure symptoms and prognosis in carefully selec-
ted patients with ischemic LV dysfunction. Identification of a viable, jeopar-
dized myocardium helps in selecting patients for whom poor left ventricular 
(LV) function, secondary to chronic ischemic heart disease, may improve after 
revascularization [1, 2]. Many studies, using various modalities, have focused 
on prediction of functional recovery, mainly regional, after revascularization [9–
14]. In contrast, studies focusing on predicting improvement in global LV function 
(which may be more relevant in the clinical setting) are scarce [3–5, 8]. The 
available evidence suggests that improvement in LV ejection fraction (LVEF) 
can be expected only when a substantial amount of viable myocardium is pre-
sent before revascularization. However, the exact relationship between improve-
ment in LVEF and the amount of viable myocardium is unclear, as emphasized 
recently by Rahimtoola [15]. Bonow [16] recently suggested that, besides 
improvement in LVEF after revascularization, improvement in heart failure 
symptoms should be used to assess the clinical benefit of revascularization.  
Thus far, mainly patients with relatively preserved LV function presen-
ting with angina pectoris instead of heart failure symptoms have been studied. 
Hence, we studied a group of patients with severely depressed LV function (mean 
LVEF 35%) who presented mainly with heart failure symptoms, and we evalua-
ted the relationship between the preoperative extent of viable myocardium and 
the postoperative improvement in LVEF and improvement in heart failure 
symptoms. The technique used to evaluate myocardial viability was nitrate –
enhanced myocardial perfusion Gated SPECT imaging (MPI).  
 
 
Materials and Methods 
 
Study Population 
Eighty-five consecutive patients with coronary artery disease and ischemic 
cardiomyopathy (73 men, 12 women; age range 56 ± 15 years; LVEF 38 ± 7%), 
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scheduled for surgical revascularization were enrolled in this prospective clini-
cal study. Clinical characteristics of the patients are shown in table 1. The reasons 
for revascularization were heart failure symptoms in 55 patients and angina pectoris 
in 30 patients, all with angiographic indications for coronary artery bypass sur-
gery according to the ACC/AHA coronary artery bypass surgery guidelines. All 
patients underwent myocardial perfusion Gated SPECT imaging (MPI) for evalua-
tion of myocardial viability before coronary artery bypass surgery (CABG). The 
decision in favour of revascularization was made independently of the SPECT 
data. Sixty-two patients had a previous myocardial infarction. All patients had sig-
nificant coronary artery disease on angiography (> 50% reduction in luminal dia-
meter of at least one major epicardial coronary artery). They had an average of 
2.6 stenosed vessels. The patients’ clinical characteristics are shown in table 1. 
Exclusion criteria for the study were unstable angina, acute myocardial infarc-
tion in the last two months, severe valvular heart disease, primary dilated cardio-
myopathy, LVEF > 45%, previous bypass surgery and decompensated heart failure.  
 
Study Protocol 
All patients underwent coronary angiography before MPI. Coronary steno-
sis equal to or greater than 70% of luminal diameter was considered significant. 
Left main coronary artery disease was reported in the presence of stenosis equal 
to or greater than 50% of the luminal diameter. Gensini angiographic score was 
calculated for all patients. Angiographic results were reported according to proper 
standards, by an experienced invasive cardiologist. Patients were followed up pro-
spectively for improvement of LV function and heart failure symptoms after CABG. 
 
Myocardial perfusion SPECT imaging 
Primary indication for the MPI was evaluation of myocardial viability 
before CABG. Fifty-five patients underwent a one-day rest-nitrate enhanced ga-
ted SPECT Tc-99m-Sestamibi protocol with 370/925 MBq, after sublingual appli-
cation of 0.5 mg nitro-glycerin (NTG) and fifty patients underwent one day nit-
rate/dipyridamole MPI study. Haemodynamic response to the nitrate was moni-
tored in all patients. Image acquisition was performed 60 minutes after injection 
of Tc-99m-Sestamibi using a single-headed Sopha Medical Vision DS7 SPECT 
gamma camera. For quantitative analysis of myocardial perfusion, a commercial 
programme for Bull’s eye analysis was used. The MultiDim program was inclu-
ded in the software of the gamma camera for assessment of left ventricular func-
tion. MPI studies were read by consensus. 
 
Analysis of Regional Function before and after Revascularization. 
Image interpretation was done using a 17-segment model and 5-point 
scoring system to assess perfusion (0 – normal perfusion; 1 – mild hypoperfu-
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sion; 2 – moderate; 3 – severe hypoperfusion and 4 – absent uptake). A segment 
was predetermined to be viable if the perfusion segment score was < 2 and wall 
thickening was present. Both wall motion and wall thickening were analyzed. A 
5-point scoring system was used to assess wall motion: 0 – normal, 1 – mild 
hypokinesia, 2 – moderate hypokinesia, 3 – severe hypokinesia, 4 – akinesia 
and 5 – dyskinesia. A segment was predetermined to be viable by function if the 
segment score was < 2 (2 – normal perfusion, 1 – moderate-severe hypoperfu-
sion; 0 – absent uptake). A viability index (VI) was calculated as value of the 
Tc-99m-Sestamibi uptake in each segment, divided by the total number of seg-
ments evaluated. A viability index > 0.9 was considered as an indication of a 
significant degree of viable myocardium. The following criteria for myocardial 
viability were used: 1. Tc-99m-Sestamibi resting uptake > 50%; 2. nitrate-indu-
ced uptake increase > 10% and nitrate activity > 65%, with resting wall motion 
abnormality (scores 2–4). The segment targets for revascularization were judged 
either completely viable, partially or totally scarred. Improvement in wall mo-
tion by one grade or more was considered the gold standard for viability (on a 
regional basis). Improvement from dyskinesia to akinesia was not considered an 
improvement in function. Summed nitrate score (SNS), summed rest score (SRS) 
and summed different score (SDS) were calculated. MPI study with the same 
protocols and analyses were done 16 ± 6 months after CABG. 
 
Analysis of Global Function Before and After Revascularization 
Left ventricular ejection fraction (LVEF) before and 16 ± 6 months 
after revascularization was assessed with Tc-99m-Sestamibi myocardial Gated-
SPECT. Improvement in global function after revascularization was defined as 
an increase of at least 5% in LVEF. This cut-off criterion had been used previo-
usly (4). Thus, the gold standard for viability on a global basis (patient basis) 
was considered an improvement of at least 5% in LVEF after revascularization. 
 
Assessment of Symptoms before and after Revascularization 
Functional status was assessed according to the New York Heart Asso-
ciation (NYHA) criteria (for symptoms of heart failure) and according to the 
Canadian Cardiovascular Society (CCS) classification (for angina pectoris). For 
each patient, the functional status before and 16 ± 6 months after revasculariza-
tion was determined by interviews and physical examinations.  
 
 
Statistical Analysis 
 
A SPSS 12 packet for statistical analysis was used. Data are expressed 
as mean ± SD. Group comparisons were performed using t tests for continuous, 
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normally distributed data. P value < 0.05 was considered statistically signifi-
cant. The correlation between the number of dysfunctional and viable (or nonvi-
able) segments and the change in LVEF after revascularization was determined 
by Pearson’s correlation test. The optimal number of segments was defined as 
that providing the maximal sum of sensitivity and specificity.  
 
 
Results 
 
Functional Outcome and Relationship with SPECT Segments  
Of the 1445 segments analyzed by MPI gated SPECT, 567 had normal 
wall motion and 878 had abnormal wall motion before revascularization. Of the 
878 dysfunctional segments, 658 were hypokinetic and 181 were akinetic and 
39 dyskinetic. The mean number of hypokinetic segments per patient was 7.6 
and akinetic segments 2.1 per patient. Eighty-five dysfunctional segments had 
normal perfusion, whereas 261 segments had a perfusion defect. According to 
the viability criteria for SPECT, 282 segments (25%) were viable before CABG 
and 344 segments non-viable (23%). Of the 878 dysfunctional segments, 278 
(31%) improved in function after revascularization, 457 (52%) remained unch-
anged, and 52 (6%) deteriorated. There was no significant difference in the 
number of dysfunctional segments and LVEF before CABG in patients with > 4 
viable segments (24% of myocardial mass) and patients <4 viable myocardial 
segments. However, we found more significant improvement in regional and 
global LV function after CABG in patients with more viable segments (> 4 seg-
ments), that linearly correlated with increase of the LVEF (r 0.78, p < 0.01). A 
significant relationship existed between the number of viable segments on SPECT 
and the magnitude of improvement in LVEF after revascularization (Fig. 2), 
suggesting that the extent of viability determined the magnitude of improve-
ment in LVEF after revascularization. In addition, a weak inverse relationship 
existed between the number of non-viable segments and the magnitude of 
improvement in LVEF (r 0.45, p 0.05). The distribution of myocardial perfusion 
patterns is shown in figure 1. 
Patients. Fifty-six patients (65%) showed significant improvement in 
LVEF (>5%) after revascularization. Clinical characteristics of the patients are 
shown in table 1. Characteristics of the patients who did and did not improve 
their LV function after revascularization are shown in table 2. Significant 
differences between the two groups were noted for the number of viable 
segments on SPECT, the number of non-viable segments on SPECT, the degree 
of left ventricular remodelling, history of angina and Q-wave myocardial infar-
ctions. A significant increase in LVEF was found in 35 patients with > 4 viable 
segments (71%) vs. 17 patients (47%) with < 4 viable segments before CABG 
(p < 0.001). Patients with > 4 viable segments had average summed  rest  scores 
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Table 1 – Табела 1 
Clinical characteristics of the patients 
Клинiчки каракtерисtики на pациенtиtе 
Variables Values 
Age    56 ± 15 (40–70) 
Gender 73 male 
 12 female 
BMI  (kg/m2)               26 (22–34) 
Obesity   40 (47%) 
DM 34 (40%) 
HTA 55 (64%) 
HLP 47 (55%) 
Smoking 39 (46%) 
PAD 16 (18%) 
Fam anamn 44 (51%) 
CVI 5 (5%) 
COPD 5 (5%) 
HBI 0 
IM 62 (72%) 
AP 67 (78%) 
CCS 2.4 ± 0.3 
NYHA 2.2 ± 0.2 
EF (%) 35 ± 10 
SVD 8 (9%) 
DVD 21 (24%) 
TVD 56 (65%) 
BMI – body mass index; DM – diabetes mellitus; HTA – Hypertension; HLP – hyperli-
pidemia; PAD – peripheral arterial disease; CVI – cerebrovascular event; COPD – chro-
nic obstuctive pulmonary disease; IM – myocardial infarction; SVD – single vessel di-
sease; DVD – double vessel disease; TVD – triple vessel disease 
Distribution of myocardial perfusion patterns before CABG
282; 20%
344; 24%
132; 9%
687; 47%
Vaible
Nonviable
Ishemia
Normal
 
CABG – coronary artery bypass surgery 
Figure 1 – Distribution of myocardial perfusion patterns before coronary 
artery bypass surgery 
Слика 1 – Дисtрибуција на tиpовиtе на миокардниtе pерфузиони наоди  
pред аорtо коронарнаtа бајpас реваскуларизација 
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(SRS) before CABG 30.3 vs. SRS 42 in patients with < 4 viable segments (p < 
0.001). Improved inotropic reserve after CABG, shown by an increase in LVEF 
on dypiridamole or NTG application, was found in 61% of patients with >4 
viable segments and in 47% in patients with < 4 viable segments. Inotropic re-
serve after CABG decrease in 18 patients (48%) with < 4 viable segments vs. 14 
pts (29%) with > 4 viable segments. There was no improvement or even dete-
rioration in global LV function in patients with absent viable segments and 
large non-viable myocardial regions before CABG. There was no improvement 
in wall motion index in patients with revascularized non-viable segments. The 
wall motion index (WMI) was higher in patients with < 4 viable myocardial 
segments (WMI 1.69 vs. 1.93; p < 0.05). 
 
Table 2 – Табела 2 
Clinical data before CABG in patients with and without improvement 
in left ventricular ejection fraction 
Клинички каракtерисtики pред аорto коронарна  
бајpас реваскуларизација кај pациенtиtе со и без pодобрување 
на лево коморнаtа ежекциона фракција 
 
 EF > 5% increase 
after CABG 
n=56 (65%) 
EF < 5% increase 
after CABG 
n = 23 (27%) 
p value 
Age 56 ± 15 57 ± 13 NS 
Gender m-48     f- 8 m-20            f-3 NS 
IM 41 (73%) 20 (86%) < 0.05 
AP 50 (87%) 13 (55%) < 0.01 
CCS 2,5 ± 0,3 2,7 ± 0.3 NS 
NYHA 2,4 ± 0.5 2,5 ± 0,4 NS 
Gensini 94,2 ± 5 96,3 ± 4 NS 
EF 36% 33% NS 
VS 5/pt 289segm (30%) 3,8/pt 89segm (22%) < 0.01 
VI 1,35 1 < 0.01 
NVS 2,5/pt 147segm (15%) 7/pt 161segm (41%) < 0.0001 
ESV (ml) 145 ± 5 180 ± 7 < 0.001 
EDV (ml) 242 ± 6 335 ± 4 < 0.001 
 
Prediction of Improvement in LVEF after Revascularization 
Sensitivity and specificity of MPI (perfusion and function) for the pre-
diction of improvement of LVEF after CABG was 83% and 79% respectively, a 
positive predictive value (PPV) of 88% and a negative predictive value (NPV) 
of 75%, which is shown in table 3. Accordingly, patients were divided into two 
groups with a similar baseline LVEF. Group 1 consisted of 49 patients with more 
than 4 viable segments before revascularization (mean 4.8 per patient). Group 2 
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consisted of 36 patients with minimal or no evidence of viability (less than four 
viable segments; mean 1.27 per patient). Figure 3 shows the individual changes 
in LVEF of the patients in the different groups. The largest increase in LVEF was 
observed in group 1 (from 34% to 47% p < 0.001); 35 (71%) of 49 patients from 
group 1 showed a significant increase in LVEF (mean increase, 11%). Patients in 
group 2 showed a modest improvement in LVEF (from 36% to 40%, p 0.04); 17 
(57%) of 36 patients showed a significant improvement in LVEF (mean increase 
8.5%, p < 0.01), mainly in patients with three viable segments. LVEF decrease in 8 
patients (22%) in this group (from 32% to 25% p < 0.001). he correlation between 
the number of viable segments and improvement of LVEF is shown in figure 2. 
 
Table 3 – Табела 3 
Accuracy of Myocardial perfusion SPECT in assessing improvement 
in global LV function 
Точносt на миокарднаtа pерфузиона tомосцинtиgрафија 
во pроцена на pодобрувањеtо на gлобалнаtа лево коморна функcија 
Index Global LV function 
(patients) 
Sensitivity 83% (40/48) 
Specificity 79% (24/29) 
Positive predictive value 88% (40/45) 
Negative predictive value 75% (24/32) 
 
14121086420
Br na hibern segm pred CABG
30
20
10
0
-10
-20
EF
 ra
zl
ik
a 
pr
ed
 i 
po
 C
AB
G
 
Figure 2 – Correlation between the number of viable segments and changes in left 
ventricular ejection fraction after revascularization (r =  0.79, p < 0.001) 
Слика 2 – Корелација pомеѓу бројоt на вијабилни сеgменtи и pромениtе на лево 
коморнаtа ежекциона фракција pо реваскуларизација (r = 0.79, p < 0.001) 
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Figure 3 – Changes in left ventricular ejection fraction in both groups 
of patients after revascularization 
Слика 3 – Промени во лево коморнаtа ежекциона фракција кај двеtе gруpи 
pациенtи pо реваскуларизацијаtа 
 
Improvement in Symptoms versus Viability  
Angina Pectoris. Sixty-0seven patients (78%) presented with primarily 
angina pectoris. Thirty-eight of them (45%) had four or more viable segments 
on SPECT and in all 35 patients (92%) the CCS score improved by one or more 
grades. The mean CCS score decreased from 2.6 to 1.2 (p < 0.01) after revascu-
larization. 
Heart Failure Symptoms. Sixty-nine patients (81%) presented with pri-
marily heart failure symptoms; 7 were in class 3. The patients were again divi-
ded into two groups, with a comparable NYHA score before revascularization 
(2.4 [group 1], 2.5 [group 2], p NS). Group 1 consisted of 49 patients with more 
than 4 viable segments. Group 2 consisted of 36 patients with less that 4 viable 
segments or no evidence of viability before revascularization. Table 4 shows the 
individual changes in the NYHA score of the patients in the two groups. The 
larger improvement in NYHA score was observed in group 1 (from 2.4 to 1.5, p 
< 0.001) in 42 patients (85%). A total of 58 (70%) of 85 patients included in the 
study showed an improvement in NYHA classification. No increase in NYHA 
score was observed in patients without viable myocardium before CABG. Still, 
8 (22%) of 36 patients showed a significant improvement in NYHA classifica-
tion. Twenty-five patients (71%) from the group with less than 4 viable seg-
ments had no improvement in NYHA functional class. Importantly, the mean 
changes in NYHA classification were significantly different between the two 
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groups (p < 0.05). With four or more viable segments on SPECT imaging consi-
dered predictive of improvement in heart failure symptoms, we found a positive 
predictive value of 79% and a negative predictive value of 74%. 
 
Table 4  –  Табела 4 
Relationship between viability and improvement in NYHA score after revascularization 
Однос pомеѓу миокардниоt вијабилиtеt и NYHA скороt 
pо реваскуларизацијаtа 
No. of viable 
segments 
Improvement 
in NYHA score 
No improvement 
in NYHA score 
          > 4               42 (85%)                        4 (8%) 
          < 4               8   (22%)                       25 (71%) 
x2 6.92, p < 0.01  
Relationship to Improvement in Heart Failure. 
 
Symptoms and Improvement in LVEF 
Of the 44 patients with an improvement in LVEF, 30 presented with 
heart failure symptoms, and 22 (74%) of them improved their NYHA class by 
one grade or more. Their mean grade improved from NYHA class II to NYHA 
class one (p < 0.01). In contrast, of the 26 patients without an improvement in 
LVEF, 22 (85%) presented with heart failure symptoms, and only 8 (31%) of 
these 26 improved their NYHA score.  
 
 
Discussion 
 
The detection of viable myocardium has become of great clinical im-
portance, due to the major prognostic role and therapeutic implications of myo-
cardial viability [1]. Clinically it is very important to perform proper preopera-
tive patient selection, aimed at achieving postoperative benefits, left ventricular 
functional and clinical improvements [2, 3]. The functional assessment of hiber-
nation myocardium and the presence of viability are clinically challenging and 
have paramount importance for the selection of the most appropriate individual 
treatment for patients with chronic severe LV dysfunction [4]. Hibernated myo-
cardium needs to be revascularized soon after its evaluation, and it needs time to 
recover. It is estimated that there is a need of 25% of viable jeopardized myo-
cardium before revascularization in order to achieve post-revascularization left 
ventricular functional recovery. The need for viability studies is growing beca-
use of the increasing number of patients presenting with symptoms of heart fai-
lure. Our study results are in close concordance with the literature data in this 
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field, showing that patients with more that four viable segments before revascu-
larization show the greatest improvements of LV functional recovery. 
There are many studies in the literature dealing with myocardial viabi-
lity assessment and postoperative recovery of LV function as well us follow up 
of the cardiac events [5]. The Allman's meta-analysis showed that in patients 
with predominant viability revascularization was associated with 80% reduction 
in the annual mortality rate [6]. The decision to revascularize must balance the risk 
of myocardial damage and the benefit of revascularizing hibernated segments 
[7, 8]. Although now we have the opportunity to detect viable myocardium with 
reasonable accuracy, controlled studies of the effects of revascularization of 
patients with viable myocardium are still a clinical challenge and are quite rare. 
Prediction of improvement in regional function after revascularization 
has been shown previously [9–14]. Most previous studies, however, included 
patients with a relatively preserved LV function and did not systematically study 
patients who had severely depressed LVEF and presented with heart failure 
symptoms [11, 17]. In this study, focusing on the patient’s severe LV function 
and heart failure symptoms, we showed a high sensitivity (83%) and specificity 
(79%) for predicting improvement in global LV function after revascularization. 
These results are in line with the literature on MPI SPECT [17]. Clinically, 
prediction of improvement in global LV function is very important issue.  
Our results showed that three features were predictive of improvement 
in LVEF: the number of viable segments on SPECT, the number of non-viable 
segments on SPECT, and the history of a Q-wave myocardial infarction. Our 
finding underscores that a substantial amount of viable myocardium (24% of the 
left ventricle) needs to be present to result in improvement in LVEF and hence 
to justify a revascularization procedure in patients with a relatively high risk of 
procedural or periprocedural complications (19). The results agree with the 
work of Bax et al. on a different patient population (with comparable baseline 
characteristics) using dobutamine echocardiography (20). Accurate identifica-
tion of patients whose LVEF can improve also has important prognostic conse-
quences, because LVEF is directly related to long-term prognosis [21]. Howe-
ver, it is important to bear in mind that on clinical grounds things are not always 
simple. Myocardial viability is only one, but a very important, factor affecting 
recovery of LV function after coronary bypass surgery. The amount of non-via-
ble tissue, degree of LV remodelling and LV volumes also have an influence on 
functional recovery. 
In this study, improvement in heart failure symptoms was observed not 
only in patients in whom LVEF improved, although those patients were a 
smaller percentage. This observation suggests that an improvement in LVEF by 
5% or more is clinically relevant, because alleviation of heart failure symptoms 
may result. Moreover, this study showed that the presence of substantial viabi-
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lity was highly predictive of improvement in heart failure symptoms after revas-
cularization: patients with a small extent of viable tissue on SPECT exhibited 
no improvement or insignificant improvements in heart failure symptoms, whe-
reas patients with an intermediate and a large extent showed a significant impro-
vement. These data are in line with previous findings [22, 23]. Eitzman et al. 
[22], in a retrospective analysis, showed that heart failure symptoms did im-
prove in patients for whom FDG PET showed viability and who underwent re-
vascularization. In addition, Di Carli et al. [23] found, similarly to us, that the 
magnitude of improvement in heart failure symptoms after revascularization 
was related to the preoperative extent of viability (assessed by FDG PET). 
 
 
Limitations 
 
Several limitations of this study need to be addressed. First, no control 
angiography was performed after revascularization. Therefore, vessel or graft 
patency remains uncertain. Second, overestimation of myocardial viability by 
perfusion scintigraphy could not be excluded. It relates to several factors: first, 
scintigraphy may detect islands of vital myocardial cells of inadequate size to 
reveal left ventricular dysfunction despite successful revascularization, or 
second, functional recovery sometimes takes a longer time if the degree of 
structural myocardial changes is very advanced. Observers were not blind to the 
angiographic and myocardial perfusion results. But there was not any inter-
observer disagreement with regard to perfusion image interpretation and 
between the cath lab operator and the supervisor of the lab. Third, long-term 
prognosis was not addressed in this study. It will be of interest to evaluate the 
long-term outcome of the patients with viable myocardium who did not improve 
in LVEF or heart failure symptoms.  
 
 
Conclusions 
 
The most important findings of this study can be summarized as follows. 
First, the magnitude of improvement in LVEF is directly related to the extent of 
dysfunctional but viable tissue. Second, using the cut -ff value of four dysfunc-
tional but viable segments, an accurate prediction of improvement in LVEF 
after revascularization is possible. Third, the presence and extent of viability is 
significantly related to the improvement in heart failure symptoms after revas-
cularization. The number of viable segments per patient was directly related to 
the improvement in LVEF after revascularization (r 0.79, p < 0.01). Further-
more, the presence of at least four viable segments predicted improvement in 
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heart failure symptoms after revascularization, with positive and negative pre-
dictive values of 88% and 75%, respectively. 
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R e z i m e 
 
KORELACIJA POME\U MIOKARDNIOT VIJABILITET 
I PODOBRUVAWETO NA LEVO KOMORNATA FUNKCIJA 
I SIMPTOMITE NA SRCEVA SLABOST PO AORTOKORONARNA 
BAJPAS REVASKULARIZACIJA 
 
Peovska I., Maksimoviќ J., Vavlukis M., Dav~eva J., Pop \or~eva D., 
Majstorov V., Kostova N., Bo{evski M. 
 
Institut za srcevi zaboluvawa, 
Institut za patofiziologija i nuklearna medicina, 
Klini~ki centar, Skopje, R. Makedonija 
 
Celi: Evaluacijata na miokardniot vijabilitet e va`en parametar 
vo predoperativnata procena i predikcijata na podobruvaweto na regio-
nalnata i globalna levo komorna (LK) funkcija po aorto koronarna bajpas 
revaskularizacija (CABG). Ne e sekoga{ sigurno dali prisustvoto na vija-
bilno miokardno tkivo e asocirano i so podobruvawe na simptomite na srceva 
slabost po revaskularizacijata. Celta na studijata e korelacija pome|u 
ekstenzitetot na vijabilniot miokard i podobruvaweto na LK funkcija po 
CABG kako i procena dali predoperativnata detekcija na miokarden vija-
bilitet mo`e da go predvidi podobruvaweto na simptomite na srcevata 
slabost. 
Materijal i metodi: Isledeni se 85 pacienti so ishemi~na srceva 
slabost (sredna levo komorna e`ekciona frakcija – LVEF-35%) kaj koi e 
indicirana aortokoronarna bajpas revaskularizacija. Kaj site pacienti 
izvedena e ednodnevna studija na miokardna perfuziona tomoscintigrafija 
(MPS) so pomo{ na Ts-99m sestamibi gated SPECT (protokol vo miruvawe i 
po aplikacija na nitroglicerin) za procena na miokarden vijabilitet. Re-
gionalnata i globalna levo komorna funkcija e procenuvana pred i 16 ± 6 
meseci po revaskularizacijata. Koristena e Bull’s kvantitativna analiza 
na miokardnite perfuzioni skenovi i 17 segmenten model na evaluacija na 
levo komornata funkcija. Simptomite na srceva slabost se procenuvani 
preku klasifikacijata na Wujor{kata srceva asocijacija (NYHA) pred i 
16 ± 6 meseci po aorto koronarnata bajpas revaskularizacija. 
Rezultati: Brojot na vijabilni segmenti na eden pacient direktno 
korelira{e so podobruvaweto na LVEF po revaskularizacijata (r 0.79, r < 
0.01). Pacientite so pove}e od 4 vijabilni segmenti, {to pretstavuva 24% 
od miokardot na levata komora, imaa senzitivnost od 83% i specifi~nost 
od 79% za predikcija na podobruvawe na LVEF. Prisustvoto na pove}e od 4 
vijabilni segmenti be{e povrzano so predikcija na podobruvawe na simp-
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tomite na srceva slabost po revaskularizacijata, i toa so pozitivna pre-
diktivna vrednost od 79% i negativna prediktivna vrednost od 74%. 
Zaklu~ok: Prisustvoto na pove}e od ~etiri vijabilni segmenti 
(nad 24% od miokardot na levata komora) proceneti so miokardna perfu-
ziona tomoscintigrafija SPECT kaj pacienti so ishemi~na srceva slabost 
pred aorto koronarna bajpas revaskularizacija signifikantno korelira so 
postoperativno podobruvawe na levo komornata funkcija i simptomite na 
srceva slabost. 
 
Klu~ni zborovi: miokardna perfuziona tomoscintigrafija, miokarden vi-
jabilitet, srceva slabost. 
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